MAGiC: VOC remains but kids with SCA appear
- PMID: 26429963
- DOI: 10.1182/blood-2015-08-662502
MAGiC: VOC remains but kids with SCA appear
Abstract
In this issue of Blood, Brousseau et al report results from the Magnesium for Children in Crisis (MAGiC; #NCT01197417) trial. This multicenter, double-blind, placebo-controlled trial compared the effects of intravenous magnesium to saline in children with sickle cell anemia (SCA) admitted to the hospital for acute vaso-occlusive pain (VOC). Although magnesium was found to be ineffective, MAGiC illustrates an effective strategy for rapid and efficient patient accrual in pediatric SCA studies.
Comment on
-
A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children.Blood. 2015 Oct 1;126(14):1651-7. doi: 10.1182/blood-2015-05-647107. Epub 2015 Jul 31. Blood. 2015. PMID: 26232172 Free PMC article. Clinical Trial.
Similar articles
-
Magnesium for treating sickle cell disease.Cochrane Database Syst Rev. 2019 Sep 9;9(9):CD011358. doi: 10.1002/14651858.CD011358.pub3. Cochrane Database Syst Rev. 2019. PMID: 31498421 Free PMC article.
-
A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children.Blood. 2015 Oct 1;126(14):1651-7. doi: 10.1182/blood-2015-05-647107. Epub 2015 Jul 31. Blood. 2015. PMID: 26232172 Free PMC article. Clinical Trial.
-
Intravenous magnesium for pediatric sickle cell vaso-occlusive crisis: methodological issues of a randomized controlled trial.Pediatr Blood Cancer. 2014 Jun;61(6):1049-54. doi: 10.1002/pbc.24925. Epub 2014 Jan 17. Pediatr Blood Cancer. 2014. PMID: 24443249 Free PMC article.
-
Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.Pediatr Blood Cancer. 2016 Feb;63(2):299-305. doi: 10.1002/pbc.25771. Epub 2015 Sep 24. Pediatr Blood Cancer. 2016. PMID: 26402148 Clinical Trial.
-
Systematic Review of l-glutamine for Prevention of Vaso-occlusive Pain Crisis in Patients with Sickle Cell Disease.Pharmacotherapy. 2019 Nov;39(11):1095-1104. doi: 10.1002/phar.2329. Epub 2019 Oct 9. Pharmacotherapy. 2019. PMID: 31505045
Cited by
-
Strategies for successful research recruitment and program implementation in pediatric emergency medicine.Acad Emerg Med. 2025 Apr 11:10.1111/acem.70038. doi: 10.1111/acem.70038. Online ahead of print. Acad Emerg Med. 2025. PMID: 40219584 No abstract available.
-
Magnesium for treating sickle cell disease.Cochrane Database Syst Rev. 2019 Sep 9;9(9):CD011358. doi: 10.1002/14651858.CD011358.pub3. Cochrane Database Syst Rev. 2019. PMID: 31498421 Free PMC article.
-
Magnesium for treating sickle cell disease.Cochrane Database Syst Rev. 2017 Apr 14;4(4):CD011358. doi: 10.1002/14651858.CD011358.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2019 Sep 09;9:CD011358. doi: 10.1002/14651858.CD011358.pub3. PMID: 28409830 Free PMC article. Updated.
-
Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trial.Trials. 2023 Aug 17;24(1):538. doi: 10.1186/s13063-023-07538-z. Trials. 2023. PMID: 37587492 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical